 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - KalVista Pharmaceuticals Inc. (KALV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-15 Sale | 2019-07-17 6:52 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.04 | $170,407 | 248,510 (Direct) | View |
| 2019-07-17 Purchase | 2019-07-19 6:38 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 61,280 | $17.79 | $1,090,296 | 975,821 (Indirect) | View |
| 2019-07-22 Sale | 2019-07-24 5:52 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 3,300 | $18.62 | $61,443 | 96,734 (Direct) | View |
| 2019-07-22 Sale | 2019-07-24 5:53 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $18.35 | $134,930 | 82,969 (Direct) | View |
| 2019-07-26 Purchase | 2019-07-30 7:37 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 56,367 | $16.99 | $957,737 | 124,566 (Indirect) | View |
| 2019-09-26 Purchase | 2019-09-30 5:23 pm | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 10,000 | $11.87 | $118,750 | 10,000 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:32 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 7,700 | $17.06 | $131,352 | 240,720 (Direct) | View |
| 2019-12-12 Sale | 2019-12-16 7:34 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 4,709 | $17.05 | $80,269 | 82,969 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:30 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 2,300 | $17.02 | $39,150 | 238,420 (Direct) | View |
| 2019-12-20 Sale | 2019-12-26 5:32 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $17.02 | $45,025 | 82,969 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:14 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200 | $17.05 | $3,410 | 238,220 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:17 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 100 | $17.11 | $1,711 | 96,634 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 5:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 100 | $17.1 | $1,710 | 82,869 (Direct) | View |
| 2020-04-29 Sale | 2020-10-20 2:08 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,261 | $17.01 | $21,444 | 236,959 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 2:11 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 993 | $17 | $16,881 | 95,641 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 2:14 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 914 | $17 | $15,539 | 81,955 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 38,539 | $17.98 | $693,025 | 195,420 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 5:34 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 16,907 | $17.92 | $303,019 | 78,734 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 5:36 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 13,986 | $17.82 | $249,167 | 67,969 (Direct) | View |
| 2020-10-29 Sale | 2020-11-02 8:01 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $17.48 | $87,394 | 62,969 (Direct) | View |
| 2020-10-30 Purchase | 2020-11-03 7:56 pm | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 115,686 | $17.24 | $1,994,068 | 1,138,179 (Indirect) | View |
| 2020-11-02 Sale | 2020-11-04 5:03 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $17.14 | $102,812 | 72,734 (Direct) | View |
| 2020-12-30 Sale | 2021-01-04 6:06 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $20.04 | $7,175 | 32,500 (Direct) | View |
| 2021-01-04 Sale | 2021-01-06 5:33 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $18.19 | $181,904 | 185,420 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-07-22 Exercise | 2019-07-24 5:53 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 7,355 | $0.0043 | 82,969 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:24 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:25 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-10-02 Option Award | 2019-10-03 5:26 pm | N/A 2029-10-01 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 7,000 | $11.21 | 7,000 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 199 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,500 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 3,010 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 199 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,500 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 7:34 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 3,010 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0.0043 | 82,969 (Direct) | View |
| 2019-12-20 Exercise | 2019-12-26 5:32 pm | N/A 2026-03-30 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 2,646 | $0.0043 | 82,969 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:32 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:35 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:36 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:37 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:38 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:39 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | Edwards Martin Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-02 8:40 pm | N/A 2030-09-30 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 7,000 | $12.88 | 7,000 (Direct) | View |
| 2020-04-29 Gift | 2020-10-20 2:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 3,000 | $0 | 236,959 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 5:58 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 140,000 | $10.2 | 140,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:01 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 65,000 | $10.2 | 65,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:02 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 20,000 | $10.2 | 20,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:05 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 85,000 | $10.2 | 85,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:08 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 25,000 | $10.2 | 25,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 6:13 pm | N/A 2030-06-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 80,000 | $10.2 | 80,000 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $6.74 | 32,500 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:06 pm | N/A 2026-12-28 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 358 | $6.74 | 32,500 (Direct) | View |
| 2021-01-04 Gift | 2021-01-06 5:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,000 | $0 | 185,420 (Direct) | View |